Selling stockholders can now immediately resell shares, likely creating sustained selling pressure. Monitor trading volume for insider distribution. The massive overhang may suppress any rallies and could lead to further price declines. Consider short-term bearish positioning or avoiding long exposure until the overhang clears.
Price Chart
Executive Summary
Firefly Neuroscience's S-3 registration statement (File No. 333-296046) became effective on June 30, 2026, allowing selling stockholders to immediately resell up to 20,499,999 shares from the March 2026 private placement. Combined with a prior effective S-3 covering up to 22,500,000 shares, total potential resale overhang exceeds 43 million shares against ~15.6 million outstanding, creating severe dilution risk. The company receives no proceeds from these resales, only from potential warrant exercises.
Key Facts
- EFFECT notice for S-3 File No. 333-296046 became effective June 30, 2026
- Registration covers resale of up to 20,499,999 shares from March 2026 private placement
- Prior S-3 (File No. 333-281281) effective May 2026 covers up to 22,500,000 shares
- Total potential resale overhang of ~43M shares vs ~15.6M shares outstanding (~276% dilution)
- Company receives no proceeds from resale; only from warrant exercises at $1.88 and $2.50 per share
Financial Impact
Potential dilution of ~276% relative to current shares outstanding; no cash proceeds to company from resale
Risk Factors
- Immediate selling pressure from resale of up to 43M shares
- Further dilution if warrants are exercised for cash (additional 13.7M shares)
- Inability to raise additional capital due to depressed stock price
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-002161 |
| Document: 9999999995-26-002161-index.html | 9999999995-26-002161 |
| Document: 9999999995-26-002161.txt | 9999999995-26-002161 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 25, 2026 4w ago | Press Release | $2.01 $0.9196 | ▼ −54.25% | ▼ −52.77% | $0.9400 (−53.23%) |
Sep 17, 2026 5w ago | Press Release | $1.28 $1.10 | ▼ −14.06% | ▼ −15.52% | $0.9400 (−26.56%) |
Jul 1, 2026 16w ago | EFFECT | $1.29 $1.07 | ▲ +17.05% | ▲ +14.87% | $0.9400 (+27.13%) |
Jun 26, 2026 17w ago | 8-K | $1.23 $1.11 | ▲ +9.76% | ▲ +9.48% | $0.9400 (+23.58%) |
Jun 23, 2026 17w ago | S-3/A | $1.19 $1.13 | ▲ +5.04% | ▲ +6.97% | $0.9400 (+21.01%) |
Jun 22, 2026 18w ago | 8-K | $1.31 $1.12 | ▼ −14.50% | ▼ −15.66% | $0.9400 (−28.24%) |
May 12, 2026 23w ago | 8-K | $1.80 $1.61 | ▲ +10.56% | ▲ +9.94% | $0.9400 (+47.78%) |
Apr 22, 2026 26w ago | 8-K | $2.06 $1.68 | ▼ −18.45% | ▼ −23.08% | $0.9400 (−54.37%) |
Mar 26, 2026 30w ago | Press Release | $3.02 $2.29 | ▼ −24.17% | ▼ −34.84% | $0.9400 (−68.87%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers